Epizyme reported $232.49M in Debt for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Abbott ABT:US $ 17090M 960M
Agios Pharmaceuticals AGIO:US $ 0.53M 0.08M
Amarin AMRN:US $ 0M 0M
Amgen AMGN:US $ 36854M 3545M
Avrobio Inc AVRO:US $ 15.02M 75K
Biogen BIIB:US $ 7275.2M 2.1M
Bluebird Bio BLUE:US $ 0M 0M
Cerulean Pharma CERU:US $ 0M 0M
Daiichi Sankyo 4568:JP Y 163461M 93M
Eisai 4523:JP Y 135758M 45837M
Epizyme EPZM:US $ 232.49M 0.38M
Exelixis EXEL:US $ 0M 0M
Gilead Sciences GILD:US $ 26208M 487M
GlaxoSmithKline GSK:LN 33328M 9155M
Glaxosmithkline GSK:US $ 33328M 9155M
IONIS PHARMACEUT IONS:US $ 1252.14M 23.19M
Karyopharm Therapeutics KPTI:US $ 302.49M 198K
Macrogenics MGNX:US $ 0M 0M
Merk MRK:US $ 31794M 1308M
Mirati Therapeutics MRTX:US $ 0M 0M
Novartis NOVN:VX SF 31275M 250M
Novartis NVS:US $ 31275M 250M
Pfizer PFE:US $ 36301M 2135M
Regeneron Pharmaceuticals REGN:US $ 2700.4M 0.7M
Seattle Genetics SGEN:US $ 0M 0M
Spectrum Pharmaceuticals SPPI:US $ 0M 0M
Vertex Pharmaceuticals VRTX:US $ 495.5M 14.3M
Xencor XNCR:US $ 0M 0M